Metraipolis › archive › dc_6efb4bcf0ec9

Limited Access to Blinatumomab in Morocco: Challenges and Implications — Europe PMC PMID:42428210

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42428210
DOI
10.7759/cureus.110511
License (as archived)
solo-consultazione
Archived
2026-10-31T16:04:39.845Z
SHA-256 of the archived text
e14b3887e2d205876d3f84471e4af0df3b13de38dc4732eaa6e33d0edaee330d
Stable URL of this page
https://metraipolis.com/documento/dc_6efb4bcf0ec9

How to cite

Limited Access to Blinatumomab in Morocco: Challenges and Implications — Europe PMC PMID:42428210 — Europe PMC (en), https://europepmc.org/article/MED/42428210 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6efb4bcf0ec9 (Metraipolis archive dc_6efb4bcf0ec9, sha256 e14b3887e2d205876d3f84471e4af0df3b13de38dc4732eaa6e33d0edaee330d)
BibTeX
@misc{dc6efb4bcf0ec9,
  title = {Limited Access to Blinatumomab in Morocco: Challenges and Implications — Europe PMC PMID:42428210},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42428210},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6efb4bcf0ec9; sha256 e14b3887e2d205876d3f84471e4af0df3b13de38dc4732eaa6e33d0edaee330d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42428210. Agents can read the archived copy with the MCP tool read_document.